Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist used to treat type 2 diabetes. It is a member of the Endocrine and Metabolic Disorders Drugs class, which are used to treat a variety of conditions related to hormones and metabolism. Lixisenatide works by stimulating the release of insulin from the pancreas, helping to reduce blood sugar levels. It is typically used in combination with other diabetes medications, such as metformin or sulfonylureas. Lixisenatide is available in both injectable and oral formulations. The injectable form is administered once daily, while the oral form is taken once weekly. Common side effects of lixisenatide include nausea, diarrhea, and headache. It is important to note that lixisenatide should not be used in patients with type 1 diabetes or diabetic ketoacidosis. Some companies in the Lixisenatide market include Sanofi, Eli Lilly, and Novo Nordisk. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
